The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
CKD-aP: Beyond the Surface
Is CKD-aP Hiding in Your Dialysis Center?
CKD-aP or Something Else? Decoding the Diagnosis
Improving Sleep and Mental Health in Patients with CKD-aP
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Ellie Kelepouris, MD, FACP, FAHA
Javed Butler, MD, MPH, MBA
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Meghan Sise, MD
Vladimir Tesar
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Difelikefalin: Managing CKD-aP for Improved Quality of Life
Jörg Latus, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
Ahmad Masri, MD, MS
IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies